Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Meggio

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Pharmacology & Therapeutics|August 23, 2002
Toward the rational design of protein kinase casein kinase-2 inhibitorsStefania Sarno, Stefano Moro, Flavio Meggio, et al.
The Biochemical Journal|August 7, 2003
Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activityFranc Llorens, Nerea Roher, Francesc A Miró, et al.
Chemmedchem|October 6, 2011
Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitorsGiorgio Cozza, Alessandra Gianoncelli, Paolo Bonvini, et al.
Cellular and Molecular Life Sciences : CMLS|July 2, 2011
Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1AStefania Sarno, Marco Mazzorana, Ryan Traynor, et al.
Biochemistry|July 19, 2008
The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptideGiorgia Poletto, Jordi Vilardell, Oriano Marin, et al.
Journal of Medicinal Chemistry|November 30, 2004
Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazoleMario A Pagano, Mariola Andrzejewska, Maria Ruzzene, et al.
Molecular and Cellular Biochemistry|December 13, 2005
Development and exploitation of CK2 inhibitorsStefania Sarno, Maria Ruzzene, Pietrogiulio Frascella, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2003
A noncanonical sequence phosphorylated by casein kinase 1 in beta-catenin may play a role in casein kinase 1 targeting of important signaling proteinsOriano Marin, Victor H Bustos, Luca Cesaro, et al.
The Biochemical Journal|July 1, 2008
The selectivity of inhibitors of protein kinase CK2: an updateMario A Pagano, Jenny Bain, Zygmunt Kazimierczuk, et al.
Biochemical and Biophysical Research Communications|July 20, 2010
Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localizationRong An, Gabriela da Silva Xavier, Francesca Semplici, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Pharmacology & Therapeutics|August 23, 2002
Toward the rational design of protein kinase casein kinase-2 inhibitorsStefania Sarno, Stefano Moro, Flavio Meggio, et al.
The Biochemical Journal|August 7, 2003
Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activityFranc Llorens, Nerea Roher, Francesc A Miró, et al.
Chemmedchem|October 6, 2011
Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitorsGiorgio Cozza, Alessandra Gianoncelli, Paolo Bonvini, et al.
Cellular and Molecular Life Sciences : CMLS|July 2, 2011
Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1AStefania Sarno, Marco Mazzorana, Ryan Traynor, et al.
Biochemistry|July 19, 2008
The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptideGiorgia Poletto, Jordi Vilardell, Oriano Marin, et al.
Journal of Medicinal Chemistry|November 30, 2004
Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazoleMario A Pagano, Mariola Andrzejewska, Maria Ruzzene, et al.
Molecular and Cellular Biochemistry|December 13, 2005
Development and exploitation of CK2 inhibitorsStefania Sarno, Maria Ruzzene, Pietrogiulio Frascella, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2003
A noncanonical sequence phosphorylated by casein kinase 1 in beta-catenin may play a role in casein kinase 1 targeting of important signaling proteinsOriano Marin, Victor H Bustos, Luca Cesaro, et al.
The Biochemical Journal|July 1, 2008
The selectivity of inhibitors of protein kinase CK2: an updateMario A Pagano, Jenny Bain, Zygmunt Kazimierczuk, et al.
Biochemical and Biophysical Research Communications|July 20, 2010
Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localizationRong An, Gabriela da Silva Xavier, Francesca Semplici, et al.
Pageof 5